Does the interaction between AF duration and CHA2DS2-VASc score risk-stratify patients with AF for stroke and systemic embolism?
The interaction between AF duration and CHA2DS2-VASc score can further risk-stratify patients with AF for stroke and systemic embolism, potentially guiding anticoagulation therapy.
There is an interaction between AF duration and CHA2DS2-VASc score that can further risk-stratify patients with AF for SSE and may be useful in guiding anticoagulation therapy.
Kaplan et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: